News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
335,717 Results
Type
Article (20161)
Company Profile (131)
Press Release (315425)
Section
Business (106255)
Career Advice (886)
Deals (18740)
Drug Delivery (96)
Drug Development (51836)
Employer Resources (80)
FDA (7752)
Job Trends (7800)
News (187917)
Policy (17429)
Tag
Academia (774)
Alliances (28086)
Alzheimer's disease (624)
Antibody-drug conjugate (ADC) (76)
Approvals (7750)
Artificial intelligence (113)
Bankruptcy (177)
Best Places to Work (5616)
Biosimilars (78)
Breast cancer (102)
Cancer (912)
Cardiovascular disease (83)
Career advice (717)
Cell therapy (135)
Clinical research (43120)
Collaboration (388)
Compensation (126)
COVID-19 (1118)
C-suite (109)
Data (912)
Diabetes (121)
Diagnostics (1804)
Drug pricing (103)
Earnings (38935)
Employer resources (74)
Events (49371)
Executive appointments (366)
FDA (8199)
Funding (265)
Gene therapy (123)
GLP-1 (539)
Government (1837)
Healthcare (6113)
Infectious disease (1185)
Inflammatory bowel disease (81)
Interviews (116)
IPO (7508)
Job creations (2435)
Job search strategy (652)
Layoffs (272)
Legal (4111)
Lung cancer (138)
Manufacturing (165)
Medical device (2031)
Medtech (2034)
Mergers & acquisitions (11420)
Metabolic disorders (416)
Neuroscience (881)
NextGen: Class of 2025 (2405)
Non-profit (918)
Northern California (924)
Obesity (263)
Opinion (185)
Patents (112)
People (33475)
Pharmaceutical (74)
Phase I (13597)
Phase II (18324)
Phase III (14520)
Pipeline (466)
Policy (89)
Postmarket research (1621)
Preclinical (4845)
Radiopharmaceuticals (158)
Rare diseases (211)
Real estate (3177)
Regulatory (12459)
Research institute (856)
Resumes & cover letters (139)
Southern California (876)
Startups (2034)
United States (8661)
Vaccines (250)
Weight loss (215)
Date
Today (6)
Last 7 days (331)
Last 30 days (1386)
Last 365 days (17893)
2025 (2404)
2024 (18147)
2023 (20292)
2022 (26575)
2021 (27323)
2020 (25419)
2019 (20351)
2018 (15769)
2017 (17438)
2016 (16361)
2015 (19010)
2014 (14903)
2013 (12610)
2012 (13533)
2011 (13848)
2010 (12769)
Location
Africa (409)
Asia (24869)
Australia (3251)
California (2164)
Canada (1008)
China (250)
Colorado (88)
Connecticut (90)
Europe (51474)
Florida (364)
Illinois (221)
Indiana (151)
Japan (95)
Maryland (312)
Massachusetts (1772)
Minnesota (115)
New Jersey (848)
New York (641)
North Carolina (441)
Northern California (924)
Ohio (75)
Pennsylvania (512)
South America (610)
Southern California (876)
Texas (278)
Washington State (221)
335,717 Results for "innate pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innate Pharma Announces Transformative Strategy to Accelerate Growth
January 10, 2025
·
6 min read
Press Releases
Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome
February 17, 2025
·
9 min read
Press Releases
Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York
January 21, 2025
·
5 min read
Outcome of Innate Pharma’s 2024 Annual General Meeting
Innate Pharma SA announced the voting results of its shareholders at the Annual General Meeting, which took place on May 23, 2024, in Marseille.
May 23, 2024
·
3 min read
Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress
Innate Pharma SA announced that four abstracts with Innate’s drug candidates have been accepted for the European Association of Hematology 2024 Congress, taking place June 13-16, 2024 in Madrid, Spain.
May 15, 2024
·
6 min read
Press Releases
Innate Pharma Releases Its 2025 Financial Calendar
November 20, 2024
·
4 min read
Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting
Regulatory News: Innate Pharma SA announced that five abstracts with Innate’s drug candidates have been accepted for the American Society of Clinical Oncology 2024 Annual Meeting, taking place May 31-June 4, 2024 in Chicago, Illinois.
May 24, 2024
·
5 min read
Press Releases
Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 20, 2024
·
4 min read
Press Releases
Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024
December 3, 2024
·
7 min read
Innate Pharma: Clarification Regarding SAR443579 Designation
Innate Pharma SA announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by Sanofi, it was mentioned that the molecule received breakthrough designation.
May 21, 2024
·
4 min read
1 of 33,572
Next
